GlassScriptPhysician profile
Harvey M Grossman
NPI 1619903036
$859.70
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $268 · 2021: $273.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $138.42 | 2019-2021 | |
| Pfizer INC. | $108.82 | 2019-2021 | |
| Cranial Technologies, INC | $108.51 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.77 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $67.66 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $49.37 | 2019 | |
| Jazz Pharmaceuticals INC. | $43.65 | 2019 | |
| Supernus Pharmaceuticals, INC. | $42.58 | 2021 | |
| Adlon Therapeutics L.P. | $38.52 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $36.53 | 2019-2021 | |
| Genentech USA, INC. | $35.88 | 2021 | |
| Dermira, INC. | $32.12 | 2020 | |
| Neos Therapeutics, LP | $24.40 | 2019-2020 | |
| Sanofi Pasteur INC. | $18.70 | 2021 | |
| Shire North American Group INC | $14.94 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.